XPO1 and posterior cortical atrophy: Gravina and others used a selective inhibition of XPO1, Selinexor (KPT-330), to demonstrate that XPO1 inhibition affects the metastatic potential of PCa cells using one model of intraprostatic tumor growth and two models of bone metastasis (Gravina et al., 2014).